Module Specification |
The information contained in this module specification was correct at the time of publication but may be subject to change, either during the session because of unforeseen circumstances, or following review of the module at the end of the session. Queries about the module should be directed to the member of staff with responsibility for the module. |
Title | Principles of Pharmacology | ||
Code | LIFE207 | ||
Coordinator |
Prof CEP Goldring Molecular and Clinical Pharmacology C.E.P.Goldring@liverpool.ac.uk |
||
Year | CATS Level | Semester | CATS Value |
Session 2016-17 | Level 5 FHEQ | First Semester | 15 |
Pre-requisites before taking this module (other modules and/or general educational/academic requirements): |
LIFE106 None |
Modules for which this module is a pre-requisite: |
Co-requisite modules: |
Linked Modules: |
Teaching Schedule |
Lectures | Seminars | Tutorials | Lab Practicals | Fieldwork Placement | Other | TOTAL | |
Study Hours |
24 |
3 |
27 | ||||
Timetable (if known) |
This refers to timetabled lectures
|
This refers to scheduled times for summative assessments
|
|||||
Private Study | 123 | ||||||
TOTAL HOURS | 150 |
Assessment |
||||||
EXAM | Duration | Timing (Semester) |
% of final mark |
Resit/resubmission opportunity |
Penalty for late submission |
Notes |
Written Exam | 2 hours | Semester 1 | 80 | Yes | Non-standard penalty applies | Assessment 1 Non-standard penalty applies for late submission, |
CONTINUOUS | Duration | Timing (Semester) |
% of final mark |
Resit/resubmission opportunity |
Penalty for late submission |
Notes |
Coursework | 1 hour | Semester 1 | 20 | Yes | Assessment 2 Notes (applying to all assessments) Assessment 207 will objective assessments (e.g. multiple choice and extended matching questions) and extended written exercises Assessment 207.1 will be an extended written exercise on a topic revealed before the assessment and unseen objective assessments (e.g. multiple choice and extended matching questions), performed together under examination conditions. |
Aims |
|
This module aims to: Develop an understanding of the quantitative aspects of drug action on cellular receptors; Demonstrate the relationship between drug efficacy and chemical structure; Introduce the basic principles of pharmacokinetics, outline the relationship between drug concentration and response, and include an introduction to the principles of toxicity of drugs and their metabolites; Provide knowledge of the molecular biology of receptors; Develop knowledge and understanding in pharmacology, and the ability to apply, evaluate and interpret this knowledge to solve pharmacological problems. |
Learning Outcomes |
|
On successful completion of this module, the students should be able to: Describe quantitative aspects of drug action;
|
|
Define the relationship between drug efficacy and chemical structure;
|
|
State key pharmacokinetic concepts such as clearance, volume of distribution, half life and steady state and to solve problems involving these parameters;
|
|
Demonstrate the role of drug concentrations in determining response to treatment;
|
|
Describe early biochemical events after drug administration that are of toxicological and biochemical significance;
|
|
Describe the principles of selective toxicity and their application to both self and non-self targets;
|
|
Demonstrate knowledge and critical understanding of the principles of pharmacology, and how this knowledge has been applied to solve problems.
|
Teaching and Learning Strategies |
|
Lecture - This refers to timetabled lectures |
|
Assessment - This refers to scheduled times for summative assessments |
Syllabus |
|
1 |
Block 1 Drugs and the peripheral nervous system Cholinergic; adrenergic; structure:activity relationships; SAR in the cholinergic system; SAR of anticholinesterases Block 2 Receptor theory/pharmacodynamics Structure: activity relationships; agonist/receptor theories; competitive agonism; non-competitive antagonism; drug binding; drug targets Block 3. Pharmacokinetics Key pharmacokinetic parameters; oral absorption; hepatic clearance; renal clearance; pharmacokinetic variability; drug interactions. Block 4 Drug disposition and metabolism Phase I oxidation; phase I reduction and hydrolysis; phase II glucuronide conjugation; phase Ii sulphate and mercapturic acid cnojugates Block 5 Selective toxicity Antimicrobials; antifungals; antivirals; anticancer therapy; basic pharmacogenetics Revision session (Block 6)
|
Recommended Texts |
|
Reading lists are managed at readinglists.liverpool.ac.uk. Click here to access the reading lists for this module. Explanation of Reading List: |